These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
388 related items for PubMed ID: 15998421
1. Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus. Chatur N, Ramji A, Bain VG, Ma MM, Marotta PJ, Ghent CN, Lilly LB, Heathcote EJ, Deschenes M, Lee SS, Steinbrecher UP, Yoshida EM. Liver Int; 2005 Aug; 25(4):723-7. PubMed ID: 15998421 [Abstract] [Full Text] [Related]
2. Mycophenolate mofetil in autoimmune hepatitis patients not responsive or intolerant to standard immunosuppressive therapy. Inductivo-Yu I, Adams A, Gish RG, Wakil A, Bzowej NH, Frederick RT, Bonacini M. Clin Gastroenterol Hepatol; 2007 Jul; 5(7):799-802. PubMed ID: 17509945 [Abstract] [Full Text] [Related]
3. Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis. Efe C, Taii HA, Ytting H, Aehling N, Bhanji RA, Hagström H, Purnak T, Muratori L, Werner M, Muratori P, Klintman D, Schiano TD, Montano-Loza AJ, Berg T, Larsen FS, Alkhouri N, Ozaslan E, Heneghan MA, Yoshida EM, Wahlin S. Dig Dis Sci; 2018 May; 63(5):1348-1354. PubMed ID: 29569003 [Abstract] [Full Text] [Related]
6. Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naïve patients. Zachou K, Gatselis N, Papadamou G, Rigopoulou EI, Dalekos GN. J Hepatol; 2011 Sep; 55(3):636-646. PubMed ID: 21238519 [Abstract] [Full Text] [Related]
8. Triple immunosuppressive therapy in steroid-resistant nephrotic syndrome children with tacrolimus resistance or tacrolimus sensitivity but frequently relapsing. Wu B, Mao J, Shen H, Fu H, Wang J, Liu A, Gu W, Shu Q, Du L. Nephrology (Carlton); 2015 Jan; 20(1):18-24. PubMed ID: 25312783 [Abstract] [Full Text] [Related]
9. Long-term outcome of patients with difficult-to-treat autoimmune hepatitis receiving mycophenolate mofetil. Liberal R, Gaspar R, Lopes S, Macedo G. Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101487. PubMed ID: 32651078 [Abstract] [Full Text] [Related]
14. Mycophenolate mofetil for autoimmune hepatitis: a single practice experience. Wolf DC, Bojito L, Facciuto M, Lebovics E. Dig Dis Sci; 2009 Nov; 54(11):2519-22. PubMed ID: 19082888 [Abstract] [Full Text] [Related]